Table 1 GWAS summary statistics: source and description
Variables | Data source | PMID | N cases | Sample size | Ethnicity |
|---|---|---|---|---|---|
GWAS of gastroesophageal reflux disease | |||||
GERD (discovery cohort) | Ong et al. (2022) | 34,187,846 | 129,080 | 602,604 | European |
GERD (replication cohort) | FinnGen-R9 | 36,653,562 | 26,184 | 346,571 | European |
GWAS of idiopathic pulmonary fibrosis | |||||
FVC | Allen et al. (2023) | 35,985,358 | – | 1048 | European |
DLCO | Allen et al. (2023) | 35,985,358 | – | 729 | European |
TFS | Oldham et al. (2023) | 36,780,644 | – | 1481 | European |
Susceptibility (discovery cohort) | Allen et al. (2022) | 35,688,625 | 4125 | 24,589 | European |
Susceptibility (replication cohort) | FinnGen-R9 | 36,653,562 | 2018 | 375,082 | European |
GWAS of smoking | |||||
Smoking initiation | Liu M et al. (2019) | 30643251 | 1,232,091 | – | European |